411
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis

, , , & , PhD
Pages 228-235 | Published online: 11 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sara Higa, Beth Devine, Vaishali Patel, Sarah Baradaran, Degang Wang & Aasthaa Bansal. (2019) Psoriasis treatment patterns: a retrospective claims study. Current Medical Research and Opinion 35:10, pages 1727-1733.
Read now
Daniel J. No, Megan S. Inkeles, Mina Amin & Jashin J. Wu. (2018) Drug survival of biologic treatments in psoriasis: a systematic review. Journal of Dermatological Treatment 29:5, pages 460-466.
Read now
Machaon Bonafede, Barbara H. Johnson, Kathleen M. Fox, Crystal Watson & Shravanthi R. Gandra. (2013) Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting. Journal of Dermatological Treatment 24:5, pages 369-373.
Read now
Benjamin Chastek, Kathleen M. Fox, Crystal Watson, Gregory Kricorian & Shravanthi R. Gandra. (2013) Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population. Journal of Dermatological Treatment 24:1, pages 25-33.
Read now

Articles from other publishers (3)

I.Y.K. Iskandar, D.M. Ashcroft, R.B. Warren, I. Evans, K. McElhone, C.M. Owen, A.D. Burden, C.H. Smith, N.J. Reynolds & C.E.M. Griffiths. (2017) Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British Journal of Dermatology 176:5, pages 1297-1307.
Crossref
Ignazio Olivieri, Salvatore D'Angelo, Angela Padula, Pietro Leccese, Angelo Nigro & Carlo Palazzi. (2013) Can we reduce the dosage of biologics in spondyloarthritis?. Autoimmunity Reviews 12:7, pages 691-693.
Crossref
Hisashi Yamanaka, Naonobu Sugiyama, Eisuke Inoue, Atsuo Taniguchi & Shigeki Momohara. (2013) Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Modern Rheumatology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.